Article History
Received: 11 April 2023
Accepted: 24 May 2023
First Online: 6 June 2023
Declarations
:
: Maruishi Pharmaceutical Cooperation (Osaka, Japan), which distributes levobupivacaine in Japan, supported our study by measuring plasma levobupivacaine concentration without any compensation. The authors do not have any other conflict of interest to disclose.